Research ID
hum0169-v2Release info
Research title
Molecular analysis to identify novel biomarker and therapeutic target for cerebrospinal tumor and preclinical investigation using patient derived orthotopic xenograft models.
Research overview
- Aims
- to compare genomic alterations between tumor tissues from Primary Central Nervous System Lymphoma (PCNSL) patients and xenograft samples derived from PCNSL patients
- Methods
- whole exome sequencing
- Participants/materials
- Nine samples, including patient derived xenograft (PDX) mice, tumor samples and peripheral blood cells from PCNSL patients
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000259 | NGS (Exome) |
| Controlled-access (Type I) | 2020-09-28 |
Data provider
- Principal investigator
- Tetsuya Yamamoto
- Affiliation
- Department of Neurosurgery, Yokohama City University
Research projects
| Name | URL |
|---|---|
Neurosurgical-Oncology lab, Yokohama City University | N/A |
Grants
| Name | Title | Project number |
|---|---|---|
KAKENHI Grant-in-Aid for Scientific Research (C) | Development of novel therapeutic target for IDH mutant gliomas with DNA hypermutation |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
A Rapid Genotyping Panel for Detection of Primary Central Nervous System Lymphoma | ||
A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma |
Controlled access users
No use of the controlled access data has been recorded.